Two genes linked to blood vessel inflammation that confers risk of severe dengue, and four genes related to metabolism that affects risk of classic dengue fever have been discovered by researchers from the Institut Pasteur, CNRS and the Institute for Research and Innovation in Health-University of Porto (i3S). These results were published in the journal PLOS Neglected Tropical Diseases.
Dengue fever is endemic to tropical and subtropical regions of East Asia and the Americas, but the virus responsible for the disease has recently spread to North America and Europe due to the introduction of its vectors - mosquitoes of the Aedes genus - into these regions. The dengue virus can lead to a wide spectrum of illness, ranging from classic dengue fever (DF) to the potentially fatal dengue shock syndrome (DSS). Ethnic diversity has long been considered as one of the factors explaining why the severe forms of dengue are more prevalent in Southeast Asia than elsewhere, as previously shown in epidemiological research, yet the phenomenon has never been explained by human genetics.
In the new work, the team of Anavaj Sakuntabhai, Director of the Functional Genetics of Infectious Diseases Unit at the Institut Pasteur and the CNRS, in collaboration with the Institute for Research and Innovation in Health-University of Porto (i3S), studied the genetics of 411 patients admitted with dengue virus infection to three hospitals in Thailand between 2000 and 2003.
Anavaj Sakuntabhai concludes: "The particular genetic risk conferred by these genes indicates that Southeast and Northeast Asians are highly susceptible to both phenotypes, while Africans are best protected against severe dengue. Europeans, on the other hand, are less susceptible to classical dengue fever but more susceptible to severe dengue fever."
This research offers insights that can help understand the pathophysiology of this infectious disease and develop new therapeutic approaches.